3) :205-8
Leger F.A., Izembart M., Dagousset F., et al. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyriod remnants in differentiated thyriod carcinoma. // Eur J Nucl Med 1998 25 (3) :242-6
Lerch H., Schober O., Kuwert T., Saur H.B. Survival of differentiated thyriod carcinoma studiedin 500 patients. // J Clin Oncol; 1997 15 (5) :2067-75
Leung S.F., Law M.W., Ho S.K. Efficacy of low-dose iodine-131 ablation of post-operative thyriod remnants: a study of 69 cases. // Br J Radiol 1992 65 (778) :905-9
Lin J.D., Chao T.C., Huang M.J., et al. Use of radioactive iodine for thyriod remnant ablation in well-differentiated thyriod carcinoma to replace thyriod reoperation. // Am J Clin Oncol; 1998 21 (1) :77-81
Lin J.D., Kao P.F., Chao T.C. The effect of radioactive iodine in thyriod remnant ablation and treatment of well differentiated thyriod carcinoma. // Br J Radiol; 1998 71 (843) :307-13
Lin W.Y., Shen Y.Y., Wang S.J. Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.// Clin Nucl Med, 1996 21 (10) :780-2
Lind P. 131I whole body scintigraphy in thyriod cancer patients. // Q J Nucl Med; 1999 43 (3) :188-94
Lippi F., Capezzone M., Angelini F., et al. Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. // Eur J Endocrinol; 2001 144 (1) :5-11
Logue JP, Tsang RW, Brierley JD, Simpson WJ Radioiodine ablation of residual tissue in thyriod cancer: relationship between administered activity, neck uptake and outcome. // Br J Radiol; 1994 67 (803) :1127-31
Makarewicz L., Mikosinski S, Karwowoska A. at al. Comparision of test and therapeutic activity kinetics of 131J. // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.63
Mandel S.J., Shankar L.K., Benard F., et al. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. // Clin Nucl Med; 2001 26 (1) :6-9
Matsushita T., Toyota S., Katoh N., Nakagawa T. Iodine-131 treatment of thyriod cance: relation between effective half-life and efficacy of treatment. // Radiat Med; 1994 12 (4) :167-70
Maxon HP, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyriod cancer. // New Eng J Med; 1983 309:937
Maxon H.R. The role of radioiodine in the treatment of childhood thyroid cancer - A dosimetric approach. // In: NIH proceedings of a workshop, September 10-11, 1992, p. 109-116. p> Mazzaferri E.L. Thyroid remnant ablation in the treatment of differentiated thyroid carcinoma. // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.77
Mazzaferri E.L., Young R.L. Papillary thyroid carcinoma: A 10-year follow...
